Cargando…
Assessment of rosehips based on the content of their biologically active compounds
In this study, an in-depth analysis of the unique set of rosehip samples from 71 Rosa genotypes was conducted with the aim to identify the most suitable ones for applications in the food and pharmaceutical industries based on the content of biologically active compounds. In the first part of our exp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328834/ https://www.ncbi.nlm.nih.gov/pubmed/28911653 http://dx.doi.org/10.1016/j.jfda.2016.12.019 |
_version_ | 1784757806322155520 |
---|---|
author | Bhave, Apurva Schulzova, Vera Chmelarova, Hana Mrnka, Libor Hajslova, Jana |
author_facet | Bhave, Apurva Schulzova, Vera Chmelarova, Hana Mrnka, Libor Hajslova, Jana |
author_sort | Bhave, Apurva |
collection | PubMed |
description | In this study, an in-depth analysis of the unique set of rosehip samples from 71 Rosa genotypes was conducted with the aim to identify the most suitable ones for applications in the food and pharmaceutical industries based on the content of biologically active compounds. In the first part of our experiments, the antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl assay and the genotypes with the highest values were selected for the follow-up analysis. In the second part of experiments, the major classes of biologically active compounds in rosehips such as carotenoids, tocopherols, flavonoids, and triterpenoic acids were further quantified using liquid chromatography-based techniques. Large variation was observed among all the analyzed compounds with intraspecific variation often hiding interspecific or intersectional differences. The compounds studied herein thus do not provide a sharp tool for chemotaxonomic resolution of the genus Rosa. High intraspecific variation indicates the necessity to screen and utilize individual rose genotypes rather than representatives of the species when searching for sources of biologically active compounds. In the final stage of the study, 10 genotypes were selected for further cultivation and use, based on the highest concentrations of the analyzed biologically active compounds. |
format | Online Article Text |
id | pubmed-9328834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taiwan Food and Drug Administration |
record_format | MEDLINE/PubMed |
spelling | pubmed-93288342022-08-09 Assessment of rosehips based on the content of their biologically active compounds Bhave, Apurva Schulzova, Vera Chmelarova, Hana Mrnka, Libor Hajslova, Jana J Food Drug Anal Original Article In this study, an in-depth analysis of the unique set of rosehip samples from 71 Rosa genotypes was conducted with the aim to identify the most suitable ones for applications in the food and pharmaceutical industries based on the content of biologically active compounds. In the first part of our experiments, the antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl assay and the genotypes with the highest values were selected for the follow-up analysis. In the second part of experiments, the major classes of biologically active compounds in rosehips such as carotenoids, tocopherols, flavonoids, and triterpenoic acids were further quantified using liquid chromatography-based techniques. Large variation was observed among all the analyzed compounds with intraspecific variation often hiding interspecific or intersectional differences. The compounds studied herein thus do not provide a sharp tool for chemotaxonomic resolution of the genus Rosa. High intraspecific variation indicates the necessity to screen and utilize individual rose genotypes rather than representatives of the species when searching for sources of biologically active compounds. In the final stage of the study, 10 genotypes were selected for further cultivation and use, based on the highest concentrations of the analyzed biologically active compounds. Taiwan Food and Drug Administration 2017-02-17 /pmc/articles/PMC9328834/ /pubmed/28911653 http://dx.doi.org/10.1016/j.jfda.2016.12.019 Text en © 2017 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Original Article Bhave, Apurva Schulzova, Vera Chmelarova, Hana Mrnka, Libor Hajslova, Jana Assessment of rosehips based on the content of their biologically active compounds |
title | Assessment of rosehips based on the content of their biologically active compounds |
title_full | Assessment of rosehips based on the content of their biologically active compounds |
title_fullStr | Assessment of rosehips based on the content of their biologically active compounds |
title_full_unstemmed | Assessment of rosehips based on the content of their biologically active compounds |
title_short | Assessment of rosehips based on the content of their biologically active compounds |
title_sort | assessment of rosehips based on the content of their biologically active compounds |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328834/ https://www.ncbi.nlm.nih.gov/pubmed/28911653 http://dx.doi.org/10.1016/j.jfda.2016.12.019 |
work_keys_str_mv | AT bhaveapurva assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds AT schulzovavera assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds AT chmelarovahana assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds AT mrnkalibor assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds AT hajslovajana assessmentofrosehipsbasedonthecontentoftheirbiologicallyactivecompounds |